Title : Relationship between Parity Status and The Incidence of Preeclampsia in Pregnant Women

Vol 6 No 11 (2023): Volume 06 Issue 11 November 2023

Article Date Published : 22 November 2023 | Page No.: 7297-7303 | Google Scholar | Crossref doi for this article

Abstract :

Preeclampsia is one of the main causes of maternal death. In 2022, there will be 31 cases of preeclampsia in the Tarokan Community Health Center service area. Preeclampsia may have a negative impact on the mother and unborn baby. The aim of this study was to determine the relationship between parity and the incidence of preeclampsia in pregnant women. This research method is analytical observational with a case control design, with a population of 50 data from pregnant women, sampling using a simple random sampling procedure with 25 respondents who experienced preeclampsia and 25 data who did not experience preeclampsia. The results of the chi-square test with a significance level of 0.05 show that the calculation results show a ρ value of (0.023).Conclusions of This study aims to determine the relationship between parity and the incidence of preeclampsia in pregnant women in the Tarokan Community Health Center working area, Kediri Regency. To recognize preeclampsia early, especially for pregnant women, it is recommended to frequently monitor their pregnancy and comply with integrated ANC.

Keywords :

Maternal Death, parity., preeclampsia, Risk Pregnancy, Woman

References :

  1. Adam, I., Rayis, DA, ALhabardi, NA, Ahmed, ABA, Sharif, ME, & Elbashir, MI (2021). Association between breastfeeding and preeclampsia in parous women: a case–control study. International Breastfeeding Journal, 16(1). https://doi.org/10.1186/s13006-021-00391-3
  2. Aouache, R., Biquard, L., Vaiman, D., & Miralles, F. (2018). Oxidative stress in preeclampsia and placental diseases. International Journal of Molecular Sciences, 19(5). https://doi.org/10.3390/ijms19051496
  3. Bergman, L., Nordlöf-Callbo, P., Wikström, A.K., Snowden, J.M., Hesselman, S., Edstedt Bonamy, A.K., & Sandström, A. (2020). Multi-Fetal Pregnancy, Preeclampsia, and Long-Term Cardiovascular Disease. Hypertension, 76(1), 167–175. https://doi.org/10.1161/HYPERTENSIONAHA.120.14860
  4. Chang, K. J., Seow, K. M., & Chen, K. H. (2023). Preeclampsia: Recent Advances in Predicting, Preventing, and Managing the Maternal and Fetal Life-Threatening Condition. International Journal of Environmental Research and Public Health, 20(4). https://doi.org/10.3390/ijerph20042994
  5. Çintesun, E., Çintesun, F.N.I., Ezveci, H., Akyürek, F., & Çelik, Ç. (2018). Systemic inflammatory response markers in preeclampsia. Journal of Laboratory Physicians, 10(03), 316–319. https://doi.org/10.4103/jlp.jlp_144_17
  6. Das, Seema, R., Bajracharya, R., Baral, G., Jabegu, B., Odland, J. Ø., & Odland, M. L. (2019). Incidence and risk factors of pre-eclampsia in the paropakar maternity and women’s hospital, Nepal: A retrospective study. International Journal of Environmental Research and Public Health, 16(19). https://doi.org/10.3390/ijerph16193571
  7. Elkafrawi, D., Sisti, G., Araji, S., Khoury, A., Miller, J., & Echevarria, B.R. (2020). Risk factors for neonatal/maternal morbidity and mortality in African American women with placental abruption. Medicina (Lithuania), 56(4). https://doi.org/10.3390/medicina56040174
  8. Garovic, V.D., White, W.M., Vaughan, L., Saiki, M., Parashuram, S., Garcia-Valencia, O., Weissgerber, T.L., Milic, N., Weaver, A., & Mielke, M.M. (2020 ). Incidence and Long-Term Outcomes of Hypertensive Disorders of Pregnancy. Journal of the American College of Cardiology, 75(18), 2323–2334. https://doi.org/10.1016/j.jacc.2020.03.028
  9. Hamzah, STR, Aminuddin, Idris, I., & Rachmat, M. (2021). Antenatal care parameters that are the risk factors in the event of preeclampsia in primigravida. Gaceta Sanitaria, 35, S263–S267. https://doi.org/10.1016/j.gaceta.2021.10.073
  10. Hastie, CE, Mackay, DF, Clemens, TL, Cherrie, MPC, Megaw, LJ, Smith, GCS, Stock, SJ, Dibben, C., & Pell, JP (2021). Antenatal exposure to uv-b radiation and preeclampsia: A retrospective cohort study. Journal of the American Heart Association, 10(13). https://doi.org/10.1161/JAHA.120.020246
  11. Hauge MG, Damm P ., & Linde, J. J. (2022). Early Coronary Atherosclerosis in Women With Previous Preeclampsia. Journal of the American College of Cardiology, 79(23), 2310–2321. https://doi.org/10.1016/j.jacc.2022.03.381
  12. Hauspurg, A., & Jeyabalan, A. (2022). Postpartum preeclampsia or eclampsia: defining its place and management among the hypertensive disorders of pregnancy. American Journal of Obstetrics and Gynecology, 226(2), S1211–S1221. https://doi.org/10.1016/j.ajog.2020.10.027
  13. Huai, J., Lin, L., Juan, J., Chen, J., Li, B., Zhu, Y., Yu, M., & Yang, H. (2021). Preventive effect of aspirin on preeclampsia in high-risk pregnant women with stage 1 hypertension. Journal of Clinical Hypertension, 23(5), 1060–1067. https://doi.org/10.1111/jch.14149
  14. Indonesian Ministry of Health. (2022). Indonesia Health Profile 2021. In Pusdatin.Kemenkes.Go.Id.
  15. Krijgsman, D., Roelands, J., Hendrickx, W., Bedognetti, D., & Kuppen, P.J. K. (2020). Hla-g: A new immune checkpoint in cancer? International Journal of Molecular Sciences, 21(12), 1–11. https://doi.org/10.3390/ijms21124528
  16. Lightman, S. L., Birnie, M. T., & Conway-Campbell, B. L. (2021). Dynamics of ACTH and cortisol secretion and implications for disease. Endocrine Reviews, 41(3), 470–490. https://doi.org/10.1210/ENDREV/BNAA002
  17. Lisowska, M., Pietrucha, T., & Sakowicz, A. (2018). Preeclampsia and Related Cardiovascular Risk: Common Genetic Background. In Current Hypertension Reports (Vol. 20, Issue 8). Current Medicine Group LLC 1. https://doi.org/10.1007/s11906-018-0869-8
  18. Ma’ayeh, M., & Costantine, M. M. (2020). Prevention of preeclampsia. Seminars in Fetal and Neonatal Medicine, 25(5), 101123. https://doi.org/10.1016/j.siny.2020.101123
  19. Mathew, R., Devanesan, B. P., Srijana, & Sreedevi, N. S. (2023). Prevalence of hypertensive disorders of pregnancy, associated factors and pregnancy complications in a primigravida population. Gynecology and Obstetrics Clinical Medicine, 3(2), 119–123. https://doi.org/10.1016/j.gocm.2023.01.002
  20. Mendoza, M., Contreras-Cristán, A., & Gutiérrez-Peña, E. (2021). Bayesian analysis of finite populations under simple random sampling. Entropy, 23(3), 1–19. https://doi.org/10.3390/e23030318
  21. Okoth, K., Chandan, J.S., Marshall, T., Thangaratinam, S., Thomas, G.N., Nirantharakumar, K., & Adderley, N.J. (2020). Association between the reproductive health of young women and cardiovascular disease in later life: Umbrella review. The BMJ, 371. https://doi.org/10.1136/bmj.m3502
  22. Pervin, J., Venkateswaran, M., Nu, U.T., Rahman, M., O’Donnell, B.F., Friberg, I.K., Rahman, A., & Frøen, J.F. (2021). Determinants of utilization of antenatal and delivery care at the community level in rural Bangladesh. PLoS ONE, 16(9 September), 1–16. https://doi.org/10.1371/journal.pone.0257782
  23. Phipps, E.A., Thadhani, R., Benzing, T., & Karumanchi, S.A. (2019). Pre-eclampsia: pathogenesis, novel diagnostics and therapies. In Nature Reviews Nephrology (Vol. 15, Issue 5, pp. 275–289). Nature Publishing Group. https://doi.org/10.1038/s41581-019-0119-6
  24. Pinto-Souza, C.C., Coeli-Lacchini, F., Luizon, M.R., Cavalli, R.C., Lacchini, R., & Sandrim, V.C. (2021). Effects of arginase genetic polymorphisms on nitric oxide formation in healthy pregnancy and in preeclampsia. Nitric Oxide – Biology and Chemistry, 109–110, 20–25. https://doi.org/10.1016/j.niox.2021.02.003
  25. Pretscher, J., Weiss, C., Dammer, U., Stumpfe, F., Faschingbauer, F., Beckmann, M. W., & Kehl, S. (2020). Influence of preeclampsia on induction of labor at term: A cohort study. In Vivo, 34(3), 1195–1200. https://doi.org/10.21873/invivo.11892
  26. Qiu, C., Lin, JC, Shi, JM, Chow, T., Desai, VN, Nguyen, VT, Riewerts, RJ, Feldman, RK, Segal, S., & Xiang, A.H. (2020). Association between Epidural Analgesia during Labor and Risk of Autism Spectrum Disorders in Offspring. JAMA Pediatrics, 174(12), 1168–1175. https://doi.org/10.1001/jamapediatrics.2020.3231
  27. Redman, E. K., Hauspurg, A., Hubel, C. A., Roberts, J. M., & Jeyabalan, A. (2019). Clinical Course, Associated Factors, and Blood Pressure Profile of Delayed-Onset Postpartum Preeclampsia. Obstetrics and Gynecology, 134(5), 995–1001. https://doi.org/10.1097/AOG.0000000000003508
  28. Rijnhart, JJM, Lamp, SJ, Valente, MJ, MacKinnon, DP, Twisk, JWR, & Heymans, MW (2021). Mediation analysis methods used in observational research: a scoping review and recommendations. BMC Medical Research Methodology, 21(1), 1–17. https://doi.org/10.1186/s12874-021-01426-3
  29. Roberts, J.M., Rich-Edwards, J.W., McElrath, T.F., Garmire, L., & Myatt, L. (2021). Subtypes of Preeclampsia: Recognition and Determining Clinical Usefulness. Hypertension, 77(5), 1430–1441. https://doi.org/10.1161/HYPERTENSIONAHA.120.14781
  30. Rymer-Haskel, N., Schushan-Eisen, I., Hass, Y., Rahav, R., Maayan-Metzger, A., & Hendler, I. (2018). Characteristics and severity of preeclampsia in young and elderly gravidas with hypertensive disease. In European Journal of Obstetrics and Gynecology and Reproductive Biology (Vol. 228, pp. 120–125). Elsevier Ireland Ltd. https://doi.org/10.1016/j.ejogrb.2018.05.038
  31. Skytte, H.N., Christensen, J.J., Gunnes, N., Holven, K.B., Lekva, T., Henriksen, T., Michelsen, T.M., & Roland, MCP (2023). Metabolic profiling of pregnancies complicated by preeclampsia: A longitudinal study. Acta Obstetricia et Gynecologica Scandinavica, 102(3), 334–343. https://doi.org/10.1111/aogs.14505
  32. Uzun, N.D., Astepe, B.S., Uzun, F., & Kale, E. (2022). Predictive value of maternal serum podocalyxin in the diagnosis of preeclampsia: A prospective case-control study. Gynecologia Polska, 93(3), 229–234. https://doi.org/10.5603/GP.a2021.0108
  33. Wiles, K., Chappell, L. C., Lightstone, L., & Bramham, K. (2020). Updates in diagnosis and management of preeclampsia in women with ckd. In Clinical Journal of the American Society of Nephrology (Vol. 15, Issue 9, pp. 1371–1380). American Society of Nephrology. https://doi.org/10.2215/CJN.15121219
  34. Wong, CKH, Au, ICH, Lau, KTK, Lau, EHY, Cowling, BJ, & Leung, GM (2022). Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalization, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: a. The Lancet, 400(10359), 1213–1222. https://doi.org/10.1016/S0140-6736(22)01586-0
  35. Yang, Y., Le Ray, I., Zhu, J., Zhang, J., Hua, J., & Reilly, M. (2021). Preeclampsia Prevalence, Risk Factors, and Pregnancy Outcomes in Sweden and China. JAMA Network Open, 4(5), 1–14. https://doi.org/10.1001/jamanetworkopen.2021.8401

Author's Affiliation

   Yuli Miftakul Komariyah
Department of Midwifery, Malang Health Polytechnic, Indonesia

   Finta Isti Kundarti
Department of Midwifery, Malang Health Polytechnic, Indonesia

Copyrights & License

Yuli Miftakul Komariyah, Finta Isti Kundarti, 2023

This work is licenced under a Creative Commons Attribution 4.0 International License.

Article Details

How to Cite :

Relationship between Parity Status and The Incidence of Preeclampsia in Pregnant Women. Yuli Miftakul Komariyah, Finta Isti Kundarti , 6(11), 7297-7303. Retrieved from https://ijcsrr.org/single-view/?id=13028&pid=13200

Most read articles by the same author(s)

Yuli Miftakul Komariyah, Finta Isti Kundarti,

View

105

Citation

Downloads

Article Details